A cost-effectiveness approach to drug subsidy and pricing in Australia.

@article{Birkett2001ACA,
  title={A cost-effectiveness approach to drug subsidy and pricing in Australia.},
  author={Donald Birkett and Anna S Mitchell and Peter McManus},
  journal={Health affairs},
  year={2001},
  volume={20 3},
  pages={104-14}
}
The Australian government offers its citizens subsidies on a select list of pharmaceuticals. For a drug to qualify for inclusion on this list, its manufacturer must demonstrate that the drug is both clinically effective and cost-effective. In part, this measure, along with others, was introduced to improve clinical and economic outcomes. Although this evidence-based system has provided transparency and consistency in decision making about which drugs will be covered, it may not have contained… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

A perspective on Australia's National Medicines Policy.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique • 2004
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…